Kyverna Therapeutics (KYTX) IPO deck
Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.
![](/content/images/size/w1304/2024/02/KYTX_01-1.png)
Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.